The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.

with the resulting molecules fully retaining the biological properties of their parental monoclonal antibodies without the need to significantly modify the structure of the bispecific antibody.

Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...

The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

The team conducted in-depth molecular-level research on the structure and function of ... in the construction of "Two-in-One" bispecific antibodies, providing strong support for the development ...

The deal structure is similar to a 2022 agreement ... includes another program targeting claudin 18.2, but with a bispecific antibody. This program, ASP2138, is in Phase 1 testing.

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

Q4 2024 Earnings Conference Call February 4, 2025 10:30 AM ETCompany ParticipantsFrancesca DeMartino - Senior Vice President, ...

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

Moreover, bispecific/multispecific antibodies that target more than one antigen or epitope ... formation and N297Q to avoid hypermannosylation in yeast (61). Further, structure-guided design assisted ...